Edition:
United States

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

58.05USD
4:00pm EDT
Change (% chg)

$2.85 (+5.16%)
Prev Close
$55.20
Open
$55.70
Day's High
$58.55
Day's Low
$55.60
Volume
420,844
Avg. Vol
197,519
52-wk High
$59.00
52-wk Low
$33.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 90.43 0.453
FY 2017 Dec '17 88.43 0.436
Sep '17 80.40 0.298
Jun '17 75.83 0.326
Mar '17 57.58 0.195
FY 2016 Dec '16 62.37 0.278
Sep '16 56.81 1.190
Jun '16 51.63 0.198
Mar '16 44.19 0.094
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 8 99.20 108.00 94.30 91.60
Quarter Ending Sep-18 7 103.70 108.30 99.13 94.90
Year Ending Dec-18 8 402.42 416.30 395.00 360.09
Year Ending Dec-19 8 488.77 525.20 450.92 453.33
Earnings (per share)
Quarter Ending Jun-18 8 0.44 0.50 0.39 0.42
Quarter Ending Sep-18 8 0.45 0.48 0.41 0.45
Year Ending Dec-18 8 1.89 2.00 1.77 1.67
Year Ending Dec-19 8 2.59 2.80 2.22 2.26
LT Growth Rate (%) 1 31.00 31.00 31.00 27.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 36.48 29.73 33.88
P/E High - Last 5 Yrs. 47.66 41.97 47.66
P/E Low - Last 5 Yrs. 14.31 23.92 25.18
Beta 1.04 0.79 0.78
Price to Sales (TTM) 8.37 3.64 8.30
Price to Book (MRQ) 8.10 3.79 4.32
Price to Tangible Book (MRQ) 8.85 4.70 5.99
Price to Cash Flow (TTM) 31.10 20.34 22.70
% Owned Institutions 98.95 1.27 2.41

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.69
Dividend Yield - 5 Year Avg -- 1.50 1.42
Dividend 5 Year Growth Rate -- -9.64 -6.64
Payout Ratio(TTM) 0.00 43.09 40.53

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 57.06 4.00 5.00
Sales (TTM) vs TTM 1 Yr. Ago 46.72 10.61 12.65
Sales - 5 Yr. Growth Rate 189.75 7.19 7.92
EPS (MRQ) vs Qtr. 1 Yr. Ago 132.00 44.55 40.28
EPS (TTM) vs TTM 1 Yr. Ago -18.71 -- --
EPS - 5 Yr. Growth Rate -- 6.42 8.01
Capital Spending - 5 Yr. Growth Rate 21.93 6.79 7.43

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.74 2.59 2.55
Current Ratio (MRQ) 4.90 3.68 3.64
LT Debt to Equity (MRQ) 90.44 10.44 12.89
Total Debt to Equity (MRQ) 90.44 14.56 17.35
Interest Coverage (TTM) -- 40.09 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 95.36 55.20 54.88
Gross Margin - 5 Yr. Avg. 94.48 52.70 52.82
EBITD Margin (TTM) 36.80 -- --
EBITD - 5 Yr. Avg 15.66 18.49 15.78
Operating Margin (TTM) 34.01 14.37 -0.49
Operating Margin - 5 Yr. Avg. 11.95 14.24 11.04
Pre-Tax Margin (TTM) 34.49 14.65 1.49
Pre-Tax Margin - 5 Yr. Avg. 8.19 14.46 11.21
Net Profit Margin (TTM) 24.18 11.24 -1.80
Net Profit Margin - 5 Yr. Avg. 8.96 10.79 7.56
Effective Tax Rate (TTM) 29.89 21.66 29.88
Effective Tax Rate - 5 Yr. Avg. -9.39 23.65 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 794,054 855,100,730 743,658,643
Net Income/Employee (TTM) 192,021 99,502,123 86,499,502
Receivable Turnover (TTM) 6.28 5.95 6.06
Inventory Turnover (TTM) 0.81 2.58 3.64
Asset Turnover (TTM) 0.58 0.91 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 14.12 10.89 10.40
Return on Assets - 5 Yr. Avg. 6.86 11.70 11.13
Return on Investment (TTM) 17.13 13.68 13.21
Return on Investment - 5 Yr. Avg. 9.32 15.17 14.44
Return on Equity (TTM) 29.05 15.46 15.18
Return on Equity - 5 Yr. Avg. 13.35 16.39 15.79
  1 Year 3 Year 5 Year
Sales % 40.57 48.29 189.75
EPS (TTM) % -28.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Supernus Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.19 -0.21 99 45
13 Week 21.72 19.71 99 23
26 Week 45.26 41.00 99 26
52 Week 37.14 21.80 99 18
YTD 38.52 34.06 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.49%
# of Holders: 411
Total Shares Held: 51,533,588
3 Mo. Net Change: 1,048,693
# New Positions: 56
# Closed Positions: 38
# Increased Positions: 187
# Reduced Positions: 183
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.